Thirty-five percent of drugs paid for by Medicare Part B in 2021 were administered in 340B hospital outpatient departments, up from 19% in 2012, new research funded by brand drug manufacturers shows.
The share of Part B drugs administered in physician offices fell from 62% in 2012 to 51% in 2021, and the share in non-340B hospital outpatient departments from 18% to 12%, the Dec. 15 study by Berkeley Research Group found. The study was funded by PhRMA, the trade group for brand name drug manufacturers.
Thirty-five percent of drugs paid for by Medicare Part B in 2021 were administered in 340B hospital outpatient departments, up from 19% in 2012, new research funded by brand drug manufacturers shows.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
